Ozempic Kidney Trial Sinks Dialysis Stocks - The Wall Street Journal
- Ozempic Kidney Trial Sinks Dialysis Stocks The Wall Street Journal
- Ozempic's early success in kidney disease trial drags on dialysis stocks Yahoo Finance
- Novo Nordisk stops Ozempic kidney trial after early signs of success Reuters
- Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease MarketWatch
- View Full Coverage on Google News